PET-Based Percutaneous Needle Biopsy.

[1]  T. Kwee,et al.  Tumor necrosis at FDG-PET is an independent predictor of outcome in diffuse large B-cell lymphoma. , 2016, European journal of radiology.

[2]  Paul Kinahan,et al.  Radiomics: Images Are More than Pictures, They Are Data , 2015, Radiology.

[3]  J. Blay,et al.  Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients , 2015, PloS one.

[4]  A. Gangi,et al.  PET/Computed Tomography and Thermoablation (Radiofrequency, Microwave, Cryotherapy, Laser Interstitial Thermal Therapy). , 2015, PET clinics.

[5]  N. O. López.  PET/Computed Tomography in Evaluation of Transarterial Chemoembolization , 2015 .

[6]  Robert J. Gillies,et al.  The effect of SUV discretization in quantitative FDG-PET Radiomics: the need for standardized methodology in tumor texture analysis , 2015, Scientific Reports.

[7]  Z. Keidar,et al.  Metabolic PET/CT-Guided Lung Lesion Biopsies: Impact on Diagnostic Accuracy and Rate of Sampling Error , 2015, The Journal of Nuclear Medicine.

[8]  Joseph O. Deasy,et al.  Feasibility of In Situ, High-Resolution Correlation of Tracer Uptake with Histopathology by Quantitative Autoradiography of Biopsy Specimens Obtained Under 18F-FDG PET/CT Guidance , 2015, The Journal of Nuclear Medicine.

[9]  M. Cuggia,et al.  High Prognostic Value of 18F-FDG PET for Metastatic Gastroenteropancreatic Neuroendocrine Tumors: A Long-Term Evaluation , 2014, The Journal of Nuclear Medicine.

[10]  T. Lehnert,et al.  Risk factor analysis of pulmonary hemorrhage complicating CT-guided lung biopsy in coaxial and non-coaxial core biopsy techniques in 650 patients. , 2014, European journal of radiology.

[11]  A. Alavi,et al.  [18F]Fluorodeoxyglucose PET for Interventional Oncology in Liver Malignancy. , 2014, PET clinics.

[12]  S. Shiraishi,et al.  Comparison of CT-Guided Percutaneous Biopsy with and Without Registration of Prior PET/CT Images to Diagnose Mediastinal Tumors , 2014, CardioVascular and Interventional Radiology.

[13]  S. Solomon,et al.  Performance of intra-procedural 18-fluorodeoxyglucose PET/CT-guided biopsies for lesions suspected of malignancy but poorly visualized with other modalities , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[14]  A. Salavati,et al.  FDG PET/CT methodology for evaluation of treatment response in lymphoma: from “graded visual analysis” and “semiquantitative SUVmax” to global disease burden assessment , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[15]  S. Rizzo,et al.  Ct-guided bone biopsy in cancer patients with suspected bone metastases: retrospective review of 308 procedures , 2014, La radiologia medica.

[16]  P. Catalano,et al.  PET/CT-guided percutaneous liver mass biopsies and ablations: targeting accuracy of a single 20 s breath-hold PET acquisition. , 2014, Clinical radiology.

[17]  J. Blay,et al.  Utility of 18F-FDG PET with a Semi-Quantitative Index in the Detection of Sarcomatous Transformation in Patients with Neurofibromatosis Type 1 , 2014, PloS one.

[18]  Sheng Xu,et al.  Image fusion during vascular and nonvascular image-guided procedures. , 2013, Techniques in vascular and interventional radiology.

[19]  Majid Maybody,et al.  Overview of navigation systems in image-guided interventions. , 2013, Techniques in vascular and interventional radiology.

[20]  P. Shyn,et al.  Interventional positron emission tomography/computed tomography: state-of-the-art. , 2013, Techniques in vascular and interventional radiology.

[21]  R. Kerlan,et al.  The changing face of percutaneous image-guided biopsy: molecular profiling and genomic analysis in current practice. , 2013, Journal of vascular and interventional radiology : JVIR.

[22]  D. Sahani,et al.  Imaging-guided biopsy of (18)F-FDG-avid extrapulmonary lesions: do lesion location and morphologic features on CT affect the positive predictive value for malignancy? , 2013, AJR. American journal of roentgenology.

[23]  A. Agrawal,et al.  18F-FDG PET/CT-directed biopsy: Does it offer incremental benefit? , 2013, Nuclear medicine communications.

[24]  H. Jadvar.  Imaging evaluation of prostate cancer with 18F-fluorodeoxyglucose PET/CT: utility and limitations , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[25]  L. Bolondi,et al.  Comparison of International Guidelines for Noninvasive Diagnosis of Hepatocellular Carcinoma , 2012, Liver Cancer.

[26]  Meena S. Vij,et al.  Image-guided biopsy: what the interventional radiologist needs to know about PET/CT. , 2012, Radiographics : a review publication of the Radiological Society of North America, Inc.

[27]  J. Bergh,et al.  Clinically used breast cancer markers such as estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are unstable throughout tumor progression. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  Bart Carelsen,et al.  Cone-beam computed tomography fusion and navigation for real-time positron emission tomography-guided biopsies and ablations: a feasibility study. , 2012, Journal of vascular and interventional radiology : JVIR.

[29]  R. Chojniak,et al.  Percutaneous Biopsy Based on PET/CT Findings in Cancer Patients: Technique, Indications, and Results , 2012, Clinical nuclear medicine.

[30]  E. Jung,et al.  Volume Navigation with Contrast Enhanced Ultrasound and Image Fusion for Percutaneous Interventions: First Results , 2012, PloS one.

[31]  P. A. Futreal,et al.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.

[32]  Katherine K. Taylor,et al.  Using endobronchial ultrasound features to predict lymph node metastasis in patients with lung cancer. , 2011, Chest.

[33]  Samuel Kadoury,et al.  Real-time FDG PET guidance during biopsies and radiofrequency ablation using multimodality fusion with electromagnetic navigation. , 2011, Radiology.

[34]  Y. Izumi,et al.  Diagnostic performance of percutaneous core needle lung biopsy under multi-CT fluoroscopic guidance for ground-glass opacity pulmonary lesions. , 2011, European journal of radiology.

[35]  S. Fanti,et al.  Consistency of FDG-PET accuracy and cost-effectiveness in initial staging of patients with Hodgkin lymphoma across jurisdictions. , 2011, Clinical lymphoma, myeloma & leukemia.

[36]  T. Baum,et al.  CT-guided biopsy of bone and soft-tissue lesions: role of on-site immediate cytologic evaluation. , 2011, Journal of vascular and interventional radiology : JVIR.

[37]  Edward S. Kim,et al.  The BATTLE trial: personalizing therapy for lung cancer. , 2011, Cancer discovery.

[38]  Y. Tomozawa,et al.  Clinical Value of CT-Guided Needle Biopsy for Retroperitoneal Lesions , 2011, Korean journal of radiology.

[39]  A. Alavi,et al.  Biopsy versus FDG PET/CT in the initial evaluation of bone marrow involvement in pediatric lymphoma patients , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[40]  S. Silverman,et al.  PET/CT-guided percutaneous biopsy of abdominal masses: initial experience. , 2011, Journal of vascular and interventional radiology : JVIR.

[41]  Juri G. Gelovani,et al.  Methodological and practical challenges for personalized cancer therapies , 2011, Nature Reviews Clinical Oncology.

[42]  Deepa Narayanan,et al.  PET‐Guided Breast Biopsy , 2011, The breast journal.

[43]  Thomas Krause,et al.  PET/CT-guided biopsies of metabolically active bone lesions: applications and clinical impact , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[44]  Ankur Kapoor,et al.  Navigation systems for ablation. , 2010, Journal of vascular and interventional radiology : JVIR.

[45]  Kemal Tuncali,et al.  Abdominal masses sampled at PET/CT-guided percutaneous biopsy: initial experience with registration of prior PET/CT images. , 2010, Radiology.

[46]  H. Abdel-Dayem,et al.  False-positive F-18 FDG uptake in PET/CT studies in pediatric patients with abdominal Burkitt's lymphoma , 2010, Nuclear medicine communications.

[47]  S. Toyooka,et al.  CT fluoroscopy-guided biopsy of 1,000 pulmonary lesions performed with 20-gauge coaxial cutting needles: diagnostic yield and risk factors for diagnostic failure. , 2009, Chest.

[48]  Wen-Sheng Tzeng,et al.  CT-guided core biopsy of lung lesions: a primer. , 2009, AJR. American journal of roentgenology.

[49]  J. Wiskirchen,et al.  PET-CT-guided interventions in the management of FDG-positive lesions in patients suffering from solid malignancies: initial experiences , 2009, European Radiology.

[50]  W. Brenner,et al.  Comparison between positron emission tomography using 2-[fluorine-18]fluoro-2-deoxy-D-glucose, conventional imaging and computed tomography for staging of breast cancer. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[51]  Barry A Siegel,et al.  Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[52]  S. Byun,et al.  Differentiation between malignant and benign pathologic fractures with F-18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography , 2008, Skeletal Radiology.

[53]  Sanjiv S Gambhir,et al.  Molecular imaging techniques in body imaging. , 2007, Radiology.

[54]  K. Huch,et al.  CT-guided interventions in orthopedics , 2007, Archives of Orthopaedic and Trauma Surgery.

[55]  Sanjiv S Gambhir,et al.  Molecular imaging: the vision and opportunity for radiology in the future. , 2007, Radiology.

[56]  M. Forsting,et al.  CT-Guided Biopsy of Small Liver Lesions: Visibility, Artifacts, and Corresponding Diagnostic Accuracy , 2007, CardioVascular and Interventional Radiology.

[57]  P. Lang,et al.  Usefulness of 18F-FDG PET-directed skeletal biopsy for metastatic neoplasm. , 2006, Academic radiology.

[58]  U. Tateishi,et al.  Glut-1 expression and enhanced glucose metabolism are associated with tumour grade in bone and soft tissue sarcomas: a prospective evaluation by [18F]fluorodeoxyglucose positron emission tomography , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[59]  J. V. van Meerbeeck,et al.  Esophageal endoscopic ultrasound with fine-needle aspiration with an on-site cytopathologist: high accuracy for the diagnosis of mediastinal lymphadenopathy. , 2005, Chest.

[60]  M. Blaufox,et al.  A metaanalysis of 18F‐2‐deoxy‐2‐fluoro‐D‐glucose positron emission tomography in the staging and restaging of patients with lymphoma , 2005, Cancer.

[61]  R. Shekhar,et al.  Automated 3-dimensional elastic registration of whole-body PET and CT from separate or combined scanners. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[62]  J. Debatin,et al.  Assessment of liver tissue after radiofrequency ablation: findings with different imaging procedures. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[63]  Thomas Beyer,et al.  Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[64]  A. Alavi,et al.  Normal variants in [18F]-fluorodeoxyglucose PET imaging. , 2004, The Radiologic clinics of North America.

[65]  G. Krol,et al.  Percutaneous CT-guided biopsy of osseous lesion of the spine in patients with known or suspected malignancy. , 2004, AJNR. American journal of neuroradiology.

[66]  A. Alavi,et al.  Evolving role of positron emission tomography in the management of patients with inflammatory and other benign disorders. , 2004, Seminars in nuclear medicine.

[67]  S. Hain,et al.  Can FDG PET be used to successfully direct preoperative biopsy of soft tissue tumours? , 2003, Nuclear medicine communications.

[68]  David R. Haynor,et al.  PET-CT image registration in the chest using free-form deformations , 2003, IEEE Transactions on Medical Imaging.

[69]  D. Evans,et al.  Malignant peripheral nerve sheath tumours in neurofibromatosis 1 , 2002, Journal of medical genetics.

[70]  M. Slovak,et al.  Diagnostic utility of bilateral bone marrow examination , 2002, Cancer.

[71]  Q. Yang,et al.  Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. , 2001, American journal of human genetics.

[72]  P. Dupont,et al.  Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods? , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[73]  D. Rossi,et al.  Fine-needle percutaneous biopsy of renal masses with helical CT guidance. , 2000, Radiology.

[74]  K. Tilling,et al.  Variable management of soft tissue sarcoma: Regional audit with implications for specialist care , 1997, The British journal of surgery.

[75]  H. Mankin,et al.  The Hazards of the Biopsy, Revisited. For the Members of the Musculoskeletal Tumor Society* , 1996, The Journal of bone and joint surgery. American volume.

[76]  P. Sheedy,et al.  CT-guided biopsy: prospective analysis of 1,000 procedures. , 1989, Radiology.

[77]  D. G. Sakamoto,et al.  The impact of coaxial core biopsy guided by FDG PET/CT in oncological patients , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[78]  Kevin Cleary,et al.  Technologies for guidance of radiofrequency ablation in the multimodality interventional suite of the future. , 2007, Journal of vascular and interventional radiology : JVIR.

[79]  Lotty Hooft,et al.  18F-fluoro-deoxyglucose positron emission tomography for post-treatment evaluation of malignant lymphoma: a systematic review. , 2006, Haematologica.

[80]  T. Hany,et al.  Bone involvement in patients with lymphoma: the role of FDG-PET/CT , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[81]  Piotr J Slomka,et al.  Software Approach to Merging Molecular with Anatomic Information , 2004 .